Literature DB >> 25214031

Thrombus in acute aortic dissection with atrial fibrillation: a treatment dilemma.

Yasuyuki Shiraishi1, Takashi Kohno2, Toru Egashira2, Yuichiro Maekawa2, Yoshitake Yamada3, Akihiro Yoshitake4, Hideyuki Shimizu4, Motoaki Sano2, Masahiro Jinzaki3, Keiichi Fukuda2.   

Abstract

Type B acute aortic dissection (AAD) is often successfully managed with medical therapy, with a lower mortality rate, compared with type A AAD. Although the number of AAD patients complicated with atrial fibrillation (AF) has increased, reflecting an aging society, there have only been a few reports regarding the association of AAD and AF. Furthermore, there is no consensus on anticoagulation therapy in ADD patients complicated with AF, despite the importance of anticoagulation therapy in AF treatment. Here, we discuss a 79-year-old man with type B AAD and chronic AF complicated with the rapid left atrial appendage (LAA) thrombus formation after discontinuation of anticoagulation therapy. Emergent contrast-enhanced computed tomography revealed type B AAD with a partially thrombosed false lumen from the bifurcation of the aorta and the left subclavian artery to above the diaphragm. Ulcer-like projection was observed in the proximal thrombosed false lumen. Ten days after discontinuation of anticoagulation therapy, LAA thrombus was detected on contrast-enhanced computed tomography, which was not observed on admission. After anticoagulation therapy was resumed, the LAA thrombus disappeared,but the partially thrombosed false lumen was enlarged. The second discontinuation of anticoagulation therapy stabilized the dissected aorta and did not cause recurrence of LAA thrombus. In conclusion,clinicians need to balance the prevention of LAA thrombus formation with the complete thrombosis of a false lumen in patients with AAD and AF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25214031     DOI: 10.1016/j.ajem.2014.07.040

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS).

Authors:  Yskert von Kodolitsch; Oliver Wilson; Helke Schüler; Axel Larena-Avellaneda; Tilo Kölbel; Sabine Wipper; Fiona Rohlffs; Christian Behrendt; E Sebastian Debus; Jens Brickwedel; Evaldas Girdauskas; Christian Detter; Alexander M Bernhardt; Jürgen Berger; Stefan Blankenberg; Hermann Reichenspurner; Tamer Ghazy; Klaus Matschke; Ralf-Thorsten Hoffmann; Norbert Weiss; Adrian Mahlmann
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

2.  Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine.

Authors:  Pier Paolo Bocchino; Ovidio De Filippo; Francesco Piroli; Paolo Scacciatella; Massimo Imazio; Fabrizio D'Ascenzo; Gaetano Maria De Ferrari
Journal:  BMC Cardiovasc Disord       Date:  2020-01-23       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.